GaryACroghanMDPhD

Oncology • Rochester, MN

Genitourinary Oncology, Melanoma, Thoracic Cancer

Associate Professor, Oncology, Mayo Medical School.

Join to view full profile

Dr. Croghan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Croghan's full profile

Already have an account?

Office
1930 44th Street NW
Rochester, MN 55901
Phone+1 507-284-3902
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1994 - 1997
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1991 - 1994
SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)Internship, Internal Medicine, 1990 - 1991
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1990
Roswell Park Cancer InstitutePost-Doctoral Fellowship, Tumor immunology, 1982 - 1986

Certifications & Licensure

MN State Medical License 1991 - 2024

Awards, Honors, & Recognition

Mayo Teachers' Hall of Fame Inductee Mayo Cinic, Rochester, Minnesota, 2008
Summa Cum Laude with Thesis Honors SUNY at Buffalo Medical School, 1990
PhD General Experimental Pathology Roswell Park Cancer Institute, 1983

Clinical Trials

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma Start of enrollment: 2005 Oct 01
Completed
Phase 2
Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2006 Oct 01
Completed
Phase 2

Publications & Presentations

PubMed

11 citations
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
Mojun Zhu, Julian R. Molina, Grace K. Dy, Gary A. Croghan, Yingwei Qi, James F. Glockner, Lorelei J. Hanson, Michelle Roos, Angelina D. Tan, Alex A. Adjei> ;Investigational New Drugs. 2020 Apr 24
13 citations
Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
Elizabeth Ann T. Lieser, Gary A. Croghan, Wendy K. Nevala, Michael J. Bradshaw, Svetomir N. Markovic, Aaron S. Mansfield> ;Lung Cancer. 2013 Oct 1
15 citations
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies
Shaji Kumar, James R. Jett, Randolph S. Marks, Ronald L. Richardson, Fernando Quevedo, Timothy J. Moynihan, Gary A. Croghan, Svetomir N. Markovic, Keith C. Bible, Rui ...> ;Investigational New Drugs. 2013 Jul 26
2 citations
Is age ≥ 70 years an important predictor of adverse events among patients enrolled in metastatic melanoma trials? Findings from pooled analyses of therapeutic trials
Aminah Jatoi, Jacob B. Allred, Vera J. Suman, Edward T. Creagan, Gary A. Croghan, Thomas Amatruda, Svetomir N. Markovic> ;Journal of Geriatric Oncology. 2012 Oct 1
20 citations
Fluctuation of systemic immunity in melanoma and implications for timing of therapy.
Alexey A. Leontovich, Roxana S. Dronca, Vera J. Suman, Martin Leonard Ashdown, Wendy K. Nevala, Michael A. Thompson, Andrew P. Robinson, Lisa A. Kottschade, Judith S. ...> ;Frontiers in Bioscience. 2012 Jan 1
20 citations
Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
Yafei Li, Zhifu Sun, Julie M. Cunningham, Marie Christine Aubry, Jason A. Wampfler, Gary A. Croghan, Cassandra Johnson, Danli Wu, Jeremiah A. Aakre, Julian R. Molina, ...> ;Clinical Cancer Research. 2011 Jun 1
Genetic variations in multiple drug action pathways and survival in advanced-stage non-small cell lung cancer treated with chemotherapy.
Yang P, Li Y, Sun Z, Cunningham JM, Aubry M, Wampfler JA, Croghan G, Johnson C, Wu D, Aakre J, Molina JR, Wang L, Pankratz VS> ;J. Clin. Oncol.. 2011-05-20
3 citations
A 51-year-old man with rapidly progressive metastatic sarcomatoid renal cell carcinoma: an apparent complete clinical response to second-line therapy with sunitinib an...
Michael J. Bradshaw, John C. Cheville, Gary A. Croghan> ;Clinical Advances in Hematology & Oncology. 2011 Jan 1
11 citations
Perivascular epithelioid cell neoplasm of the uterine cervix: an unusual tumor in an unusual location.
Michael J. Bradshaw, Andrew L. Folpe, Gary A. Croghan> ;Rare Tumors. 2010 Dec 2
29 citations
A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: A phase 2 consortium study
Gary A. Croghan, Vera J. Suman, William J. Maples, Mark R. Albertini, Gerald P. Linette, Lawrence E. Flaherty, John R. Eckardt, Cynthia X. Ma, Svetomir N. Markovic, Ch...> ;Cancer. 2010 Jul 15
36 citations
Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States
Ivana T. Croghan, Richard D. Hurt, Jon O. Ebbert, Gary A. Croghan, Octavius Polk, Philip J. Stella, Paul J. Novotny, Jeff A. Sloan, Charles L. Loprinzi> ;Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health. 2010 Feb 1
13 citations
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy
Tamana Walia, J Fernando Quevedo, Timothy J. Hobday, Gary A. Croghan, Aminah Jatoi> ;Therapeutics and Clinical Risk Management. 2008 Dec 5
20 citations
A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer
Daniel A. Laheru, Gary A. Croghan, Ronald M. Bukowski, Michelle A. Rudek, Wells A. Messersmith, Charles Erlichman, Robert Pelley, Antonio Jimeno, Ross C. Donehower, Jo...> ;Clinical Cancer Research. 2008 Sep 1
14 citations
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.
Farrah J. Mateen, Aminah Jatoi, Timothy W. Lineberry, Dawn Aranguren, Edward T. Creagan, Gary A. Croghan, James R. Jett, Randolph S. Marks, Julian R. Molina, Ronald L....> ;Psycho-Oncology. 2008 Jul 1
VEGF A, C, and D levels in malignant pleural effusions.
Croghan GA, Nichols F, Cassivi S, Nevala W, Daniels C, Thompson M, Schroeder D, Markovic SN> ;J. Clin. Oncol.. 2008-05-20
A phase I study of the raf kinase/VEGF-R inhibitor sorafenib in combination with bortezomib in patients with advanced malignancy.
Kumar S, Marks RS, Richardson R, Quevedo F, Croghan GA, Markovic SN, Qin R, Tan AD, Molina JR, Erlichman CE, Adjei AA> ;J. Clin. Oncol.. 2008-05-20
Efficacy of PS-341 in combination with paclitaxel (PAC) and carboplatin (CBDCA) for the treatment of metastatic melanoma (MM): A phase II consortium study.
Maples WJ, Suman V, Croghan GA, Albertini MR, Linette G, Flaherty LE, Eckardt J, Amatruda T, Erlichman CE> ;J. Clin. Oncol.. 2008-05-20
Phase I trial of the mTOR inhibitor RAD001 (R) in combination with two schedules of the vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor PT...
Dy GK, Croghan GA, Qi Y, Glockner J, Hanson L, Roos M, Tan AD, Molina JR, Adjei AA> ;J. Clin. Oncol.. 2008-05-20
35 citations
Second primary tumors following tobacco dependence treatments among head and neck cancer patients.
Yolanda I. Garces, Darrell R. Schroeder, Liza M. Nirelli, Gary A. Croghan, Ivana T. Croghan, Robert L. Foote, Richard D. Hurt> ;American Journal of Clinical Oncology. 2007 Oct 1
78 citations
A Phase II Study of ABT-510 (Thrombospondin-1 Analog) for the Treatment of Metastatic Melanoma
Svetomir N. Markovic, Vera J. Suman, Ravi A. Rao, James N. Ingle, Judith S. Kaur, Lori A. Erickson, Henry C. Pitot, Gary A. Croghan, Robert R. McWilliams, Jaime R. Mer...> ;American Journal of Clinical Oncology. 2007 Jun 1
77 citations
Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer
Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia...> ;Clinical Cancer Research. 2007 May 1
68 citations
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Ivana T. Croghan, Richard D. Hurt, Shaker R. Dakhil, Gary A. Croghan, Jeff A. Sloan, Paul J. Novotny, Kendrith M. Rowland, Albert M. Bernath, Mary L. Loots, Nguyet A. ...> ;Mayo Clinic Proceedings. 2007 Feb 1
38 citations
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
Ian D. Davis, Gregory A. Wiseman, Fook-Thean Lee, Denise N. Gansen, Wendie Hopkins, Anthony T. Papenfuss, Zhanqi Liu, Timothy J. Moynihan, Gary A. Croghan, Alex A. Adj...> ;Cancer Immunity. 2007 Jan 1
97 citations
The prevalence of weight concerns in a smoking abstinence clinical trial.
Matthew M. Clark, Richard D. Hurt, Ivana T. Croghan, Christi A. Patten, Paul J. Novotny, Jeff A. Sloan, Shaker R. Dakhil, Gary A. Croghan, Edward J. Wos, Kendrith M. R...> ;Addictive Behaviors. 2006 Jul 1
A phase II study of ABT-510 for the treatment of metastatic melanoma.
Markovic S, Suman V, Rao R, Creagan E, Maples W, Kaur J, McWilliams R, Allred J, Pitot H, Croghan G, Humerickhouse R> ;J. Clin. Oncol.. 2006-06-20
Join now to see all